Columbus Macro LLC Invests $3.18 Million in iShares Biotechnology ETF $IBB

Columbus Macro LLC purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 18,825 shares of the financial services provider’s stock, valued at approximately $3,177,000.

Several other institutional investors and hedge funds have also bought and sold shares of the company. BNP Paribas Financial Markets increased its holdings in iShares Biotechnology ETF by 313.2% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,915,395 shares of the financial services provider’s stock valued at $276,526,000 after buying an additional 1,451,820 shares during the period. JPMorgan Chase & Co. boosted its position in shares of iShares Biotechnology ETF by 27.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,060,048 shares of the financial services provider’s stock worth $153,039,000 after acquiring an additional 226,852 shares in the last quarter. Jefferies Financial Group Inc. acquired a new stake in shares of iShares Biotechnology ETF during the 3rd quarter worth approximately $65,083,000. Barclays PLC increased its stake in iShares Biotechnology ETF by 6.7% in the third quarter. Barclays PLC now owns 416,191 shares of the financial services provider’s stock valued at $60,085,000 after acquiring an additional 26,032 shares during the last quarter. Finally, Focus Partners Wealth increased its stake in iShares Biotechnology ETF by 8.8% in the third quarter. Focus Partners Wealth now owns 116,844 shares of the financial services provider’s stock valued at $16,878,000 after acquiring an additional 9,404 shares during the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of IBB opened at $160.41 on Monday. The firm has a 50 day simple moving average of $171.17 and a two-hundred day simple moving average of $164.38. iShares Biotechnology ETF has a one year low of $107.43 and a one year high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were issued a dividend of $0.1218 per share. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $0.49 dividend on an annualized basis and a dividend yield of 0.3%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.